The "Halftime Report" traders give their trades for the second half.» Read More
Many hedge funds are underperforming this year because they're in the same crowded--and losing--trades.
CNBC's Seema Mody reports on the strong interest in JD.com; and the FMHR traders provide perspective.
RBC Capital Markets managing director, Mark Mahaney is one of the most bullish Facebook analysts on the Street. Mahaney says the social media company has two very identifiable revenue opportunities coming out.
Brooks Macdonald's Gemma Godfrey, explains why Europe and China are her top global picks right now.
CNBC's Kate Kelly provides insight to Goldman Sachs' analysis of hedge fund performance through mid-May.
Best Buy is still the worst S&P stock so far this year. FMHR trader Dr. J is bullish on the stock because he says the company is cutting costs. Stephen Weiss is a bear.
FMHR trader Joe Terranova predicts a dramatic turn in the markets as we enter the summer.
The FMHR traders agree the most surprising trade that could work for investors ahead is bonds.
Liz Gannes, Re/code senior editor, discusses the origins of the social media phenomenon, "Throwback Thursday." To date 250 million Instagram photos have been tagged #TBT or # throwbackthursday.
CNBC's Meg Tirrell reports antibiotics cost much less than drugs for chronic or rare diseases. The FMHR traders discuss the consequences of when drugs get too cheap.
CNBC's Phil LeBeau reports the NTSB is saying the FAA needs better tests for battery overheating issues.
The Futures Now team discusses high gas prices, and whether it's going to get better for the consumer.
CNBC.com Technology Editor Matt Hunter and Tom's Guide Reviews Editor Mike Prospero discuss how to keep your passwords secure amid numerous online security breaches.
CNBC's Jane Wells reports from the cannabis convention in Colorado where she looks at how many women are getting involved in the industry.
The FMHR traders reveal their final trades of the hour.
The "Fast Money" traders share their final trades of the day.
AstraZeneca told Pfizer its final offer isn't good enough. Mark Schoenebaum, ISI Group biotech & pharma analyst, provides insight to the potential deal.
Ron Sloan, Invesco Charter Fund senior portfolio manager, explains why he sees the market narrowing towards a stock pickers market. He shares his top picks with pricing power.
Each of the "Fast Money Halftime Report" traders own Apple, and explain what catalysts they're watching.
FMHR trader Stephanie Link and Josh Brown debate whether stocks or bonds are a safer bet right now. Joe Terranova says Apple is a "bond-like equity."